Navigation Links
Cardium Announces Retirement of Director
Date:1/26/2009

SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) today reported that Ronald I. Simon (age 70) has retired from the Company's Board of Directors. The resignation reduces the size of Cardium's board to seven directors. "We thank Dr. Simon for his service to the Board and wish him all the best in the years ahead," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium Therapeutics.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including InnerCool's new RapidBlue(TM) System, which just received FDA clearance, and its CoolBlue(TM) System, please visit www.innercool.com.

Cardium also has two biologic candidates in clinical development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe chronic diabetic wounds. TRC's lead product candidate, Excellarate(TM), is a DNA-activated collagen ge
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
2. Cardiums InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
3. Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
4. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
5. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
6. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
7. Cardium Announces Follow-On Direct Investment by Institutional Investor
8. Cardium Selected for Inclusion in Russell Microcap Index
9. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
10. Cardium Launches New AWARE Clinical Study Website
11. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IM,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroSc...HylandSeeds,adivisionofThompsonsLimitedofBlenheim,...owAgroSciences,currentseedsbusinessasthecompanyant...andDowAgroSciencesHerbicideTolerantTraitTechnology...earfuture. ,, "Thisacquisitionbringstogethertwo...
(Date:11/24/2009)...d,November24/PRNewswire-FirstCall/--deCODE,genetic...lofits,"firstday"motionsbytheU.S.BankruptcyCourtfo...DElastweekfiledavoluntarypetitionfor,reliefunderCh...ruptcyCourt. , TheordersissuedbytheBankruptcy...sduringtheChapter11proceedings.Inparticular,the,co...
(Date:11/24/2009)...RNewswire/--BlueMarbleEnergyCorp.announcedtodaytha...OPDA)wererecentlyawarded$2millionbyWashingtonState...vate/publicpartnershiptoconstructthestate,sfirstsp..., "Thisinvestmentwillsignificantlyspeedthedevel...colnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."W...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ:...y,today,announcedthatithassubmittedaMAAtotheEurope...senzymereplacementtherapyindevelopment,forthetreat...applicationforvelaglucerasealfathathasbeensubmitte...da. , Basedonaglobalsupplyshortageofthecurren...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...roved for Treatment-Experienced Adult ...une 24 Boehringer Ingelheim,Pharmaceuticals, Inc....istration (FDA) granted approval of Aptivus(R) (ti...mation for treatment-experienced,pediatric patient...e oral,solution formulation, which is a new dosage...
...oners earns highest environmental award,from EPA, ...rgest non-profit research and development organiza...ased toners and resins has earned a,2008 President...d will be presented at the 2008 Presidential Green..., D.C. on June 24th. The EPA,s,Presidential Green ...
...y to visit independent Ukraine also visits ... WASHINGTON, June 24 On June 4, 2008, U.S. Commer.... cabinet official to visit,MaxWell Biocorporation...acility in Boryspil, Ukraine., (Logo: http://www... Gutierrez joined the founder, President and CEO ...
Other Biology Technology:New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 2New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 3New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 4New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 5New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 6New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 7New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 8New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients 9Battelle Earns 2008 Presidential Green Chemistry Award 2U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporation's New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine 2
(Date:11/24/2009)...llege of Medical Toxicology (ACMT) have signed an ... Journal of Medical Toxicology (JMT), the offici...It was previously published by the University of P...xicology , an international, peer-reviewed journal...ce of medical toxicology. The quarterly journal f...
(Date:11/24/2009)...n Spanish . , The presence of increased bod... substances in the blood, hinders the loss and mai...oject of the University of Navarra conducted by Es...of Pharmacy. , The project, entitled "A nutrigen...trol of body weight and inflammation," examines ho...
(Date:11/23/2009)...e Conservation Society says that western lowland g... Congopart of the "mother lode" of more than 125,0...asingly threatened by growing humans activity in t...the swamp forests adjacent to the southwest border...confirmed that high densities of the great apes st...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Chemist receives NIH New Innovator grant for genetic drug research 10360 1Chemist receives NIH New Innovator grant for genetic drug research 10360 2MSU becoming center of excellence for Parkinsons research 10356 1MSU becoming center of excellence for Parkinsons research 10356 2Stem Cells Being Tested to Fight Pancreatic Cancer 59455 1Stem Cells Being Tested to Fight Pancreatic Cancer 59455 2
...earch shows that a chemical compound found in many...nd other deodorizing products, may be harmful to t... Institute of Environmental Health Sciences (NIEHS...und that exposure to a volatile organic compound (...se modest reductions in lung function. , "Even a s...
...some microorganisms manage to exist and even thriv...ng hot springs? A team of scientists from the Weiz... Prof. Avigdor Scherz, has found that a switch in ...in) can make a difference between functioning best...ing in extreme heat. The results of their research...
...hold remedy millennia old is being reinstated: hon...the most modern antibiotics. For several years now...been clocking up largely positive experience with ...fected with multi-resistant bacteria often healed ... from Düsseldorf, Homburg and Berlin they now want...
Other Biology News:Chemical in many air fresheners may reduce lung function 2Chemical in many air fresheners may reduce lung function 3Bacteria beat the heat 2Honey helps problem wounds 2Honey helps problem wounds 3
pBICEP-CMV-3 Expression Vector from Sigma-Aldrich
... direct antibiotic-based selection system for reco...nds solely on colony survival, eliminating the nee...ensive process provides close to 100% accuracy in ...l platform for robot colony picking. This cloning ...
Eppendorf Thermomixer from Eppendorf North America
Mouse Anti-Human KCTD13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: